22,683.40
-393.51
(-1.71%)
7,465.56
-142.82
(-1.88%)
4,254.60
-151.32
(-3.43%)
4,027.26
-93.02
(-2.258%)
4,868.22
-151.88
(-3.025%)
15,782.22
-561.86
(-3.438%)
60,541.9900
+747.3500
(1.250%)
22/01/2025 11:26
大行報告 | 蔚小理、藥明系、電訊股、比亞迪及領展最新評級/目標價,一表盡掌握
.高盛點評蔚小理,降理想(02015)、蔚來(09866)目標卻升小鵬(09868)目標
.高盛調升藥明系目標價,其中藥明康德(02359)目標由58元升至62.4元
.大摩看好中資電訊股,皆維持超配評級



1069,,新聞,專題透視,reports